Share Repurchase

Curtiss-Wright Boosts Shareholder Returns with $550 Million Buyback and Consistent Dividend

Curtiss-Wright

Curtiss-Wright Boosts Shareholder Returns with $550 Million Buyback and Consistent Dividend

Farmingdale, NY – November 20, 2025 – Curtiss-Wright Corporation (NYSE: CW) has significantly enhanced its commitment to shareholder value, announcing a substantial increase in its share repurchase authorization to an impressive $550 million. Concurrently, the diversified manufacturing company declared a quarterly dividend of $0.24 per share, signaling robust financial health and

By MarketMinute
United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

United Therapeutics

United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

In a financial landscape often fixated on consistent dividend payouts, United Therapeutics Corporation (NASDAQ: UTHR) stands out with a distinct capital allocation strategy. Contrary to market discussions about "dividend increases," the biotechnology firm has publicly stated it does not anticipate paying dividends in the immediate future. Instead, the

By MarketMinute